AAAAAA
Results: 1-25/45
Authors:
Cheung, IY
Cheung, NKV
Citation: Iy. Cheung et Nkv. Cheung, Quantitation of marrow disease in neuroblastoma by real-time reverse transcription-PCR, CLIN CANC R, 7(6), 2001, pp. 1698-1705
Authors:
Mora, J
Cheung, NKV
Chen, LS
Qin, J
Gerald, W
Citation: J. Mora et al., Loss of heterozygosity at 19q13.3 is associated with locally aggressive neuroblastoma, CLIN CANC R, 7(5), 2001, pp. 1358-1361
Authors:
Kushner, BH
Kramer, K
Cheung, NKV
Citation: Bh. Kushner et al., Phase II trial of the anti-G(D2) monoclonal antibody 3F8 and granulocyte-macrophage colony-stimulating factor for neuroblastoma, J CL ONCOL, 19(22), 2001, pp. 4189-4194
Authors:
Merino, ME
Navid, F
Christensen, BL
Toretsky, JA
Helman, LJ
Cheung, NKV
Mackall, CL
Citation: Me. Merino et al., Immunomagnetic purging of Ewing's sarcoma from blood and bone marrow: Quantitation by real-time polymerase chain reaction, J CL ONCOL, 19(16), 2001, pp. 3649-3659
Authors:
Kushner, BH
Yeung, HWD
Larson, SM
Kramer, K
Cheung, NKV
Citation: Bh. Kushner et al., Extending positron emission tomography scan utility to high-risk neuroblastoma: Fluorine-18 fluorodeoxyglucose positron emission tomography as sole imaging modality in follow-up of patients, J CL ONCOL, 19(14), 2001, pp. 3397-3405
Authors:
Kushner, BH
Wolden, S
LaQuaglia, MP
Kramer, K
Verbel, D
Heller, G
Cheung, NKV
Citation: Bh. Kushner et al., Hyperfractionated low-dose radiotherapy for high-risk neuroblastoma after intensive chemotherapy and surgery, J CL ONCOL, 19(11), 2001, pp. 2821-2828
Authors:
Kushner, BH
Cheung, NKV
Kramer, K
Dunkel, IJ
Calleja, E
Boulad, F
Citation: Bh. Kushner et al., Topotecan combined with myeloablative doses of thiotepa and carboplatin for neuroblastoma, brain tumors, and other poor-risk solid tumors in childrenand young adults, BONE MAR TR, 28(6), 2001, pp. 551-556
Authors:
Kramer, K
Gerald, WL
Kushner, BH
Larson, SM
Hameed, M
Cheung, NKV
Citation: K. Kramer et al., Disialoganglioside G(D2) loss following monoclonal antibody therapy is rare in neuroblastoma, MED PED ONC, 36(1), 2001, pp. 194-196
Authors:
Cheung, IY
Cheung, NKV
Citation: Iy. Cheung et Nkv. Cheung, Detection of microscopic disease: Comparing histology, immunocytology, andRT-PCR of tyrosine hydroxylase, GAGE, and MAGE, MED PED ONC, 36(1), 2001, pp. 210-212
Authors:
Cheung, NKV
Kushner, BH
LaQuaglia, M
Kramer, K
Gollamudi, S
Heller, G
Gerald, W
Yeh, S
Finn, R
Larson, SM
Wuest, D
Byrnes, M
Dantis, E
Mora, J
Cheung, IY
Rosenfield, N
Abramson, S
O'Reilly, RJ
Citation: Nkv. Cheung et al., N7: A novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of age, MED PED ONC, 36(1), 2001, pp. 227-230
Authors:
Mora, J
Cheung, NKV
Juan, G
Illei, P
Cheung, I
Akram, M
Chi, S
Ladanyi, M
Cordon-Cardo, C
Gerald, WL
Citation: J. Mora et al., Neuroblastic and Schwannian stromal cells of neuroblastoma are derived from a tumoral progenitor cell, CANCER RES, 61(18), 2001, pp. 6892-6898
Authors:
Modak, S
Kramer, K
Gultekin, SH
Guo, HF
Cheung, NKV
Citation: S. Modak et al., Monoclonal antibody 8H9 targets a novel cell surface antigen expressed by a wide spectrum of human solid tumors, CANCER RES, 61(10), 2001, pp. 4048-4054
Authors:
Lo Piccolo, MS
Cheung, NKV
Cheung, IY
Citation: Ms. Lo Piccolo et al., GD2 synthase - A new molecular marker for detecting neuroblastoma, CANCER, 92(4), 2001, pp. 924-931
Authors:
Kramer, K
Kushner, B
Heller, G
Cheung, NKV
Citation: K. Kramer et al., Neuroblastoma metastatic to the central nervous system - The Memorial Sloan-Kettering Cancer Center experience and a literature review, CANCER, 91(8), 2001, pp. 1510-1519
Authors:
Mora, J
Cheung, NKV
Chen, LS
Qin, J
Gerald, W
Citation: J. Mora et al., Survival analysis of clinical, pathologic, and genetic features in neuroblastoma presenting as locoregional disease, CANCER, 91(2), 2001, pp. 435-442
Authors:
Mora, J
Cheung, NKV
Gerald, WL
Citation: J. Mora et al., Genetic heterogeneity and clonal evolution in neuroblastoma, BR J CANC, 85(2), 2001, pp. 182-189
Authors:
Cheung, NKV
Citation: Nkv. Cheung, Anti-idiotype immunotherapy strategies for brain tumors, BRAIN TUMOR IMMUNOTHERAPY, 2001, pp. 193-204
Authors:
Mora, J
Cheung, NKV
Kushner, BH
LaQuaglia, MP
Kramer, K
Fazzari, M
Heller, G
Chen, LS
Gerald, WL
Citation: J. Mora et al., Clinical categories of neuroblastoma are associated with different patterns of loss of heterozygosity on chromosome arm 1p, J MOL DIAGN, 2(1), 2000, pp. 37-46
Authors:
Cheung, NKV
Guo, HF
Heller, G
Cheung, IY
Citation: Nkv. Cheung et al., Induction of Ab3 and Ab3 ' antibody was associated with long-term survivalafter anti-G(D2) antibody therapy of stage 4 neuroblastoma, CLIN CANC R, 6(7), 2000, pp. 2653-2660
Authors:
Cheung, NKV
Citation: Nkv. Cheung, Detecting neuroblastoma using bone marrow aspiration and bone marrow biopsy, J PED H ONC, 22(1), 2000, pp. 86-87
Authors:
Wolden, SL
Gollamudi, SV
Kushner, BH
LaQuaglia, M
Kramer, K
Rosen, N
Abramson, S
Cheung, NKV
Citation: Sl. Wolden et al., Local control with multimodality therapy for stage 4 neuroblastoma, INT J RAD O, 46(4), 2000, pp. 969-974
Authors:
Bergman, I
Basse, PH
Barmada, MA
Griffin, JA
Cheung, NKV
Citation: I. Bergman et al., Comparison of in vitro antibody-targeted cytotoxicity using mouse, rat andhuman effectors, CANCER IMMU, 49(4-5), 2000, pp. 259-266
Authors:
Mora, J
Akram, M
Cheung, NKV
Chen, L
Gerald, WL
Citation: J. Mora et al., Laser-capture microdissected Schwannian and neuroblastic cells in stage 4 neuroblastomas have the same genetic alterations, MED PED ONC, 35(6), 2000, pp. 534-537
Authors:
Cheung, IY
Chi, SN
Cheung, NKV
Citation: Iy. Cheung et al., Prognostic significance of GAGE detection in bone marrows on survival of patients with metastatic neuroblastoma, MED PED ONC, 35(6), 2000, pp. 632-634
Authors:
Cheung, NKV
Guo, HF
Cheung, IY
Citation: Nkv. Cheung et al., Correlation of anti-idiotype network with survival following anti-G(D2) monoclonal antibody 3F8 therapy of stage 4 neuroblastoma, MED PED ONC, 35(6), 2000, pp. 635-637